Solitron Devices INC Form 4 insider transactions

Howard Timothy Eriksen and 2 others reported changes in beneficial ownership of Solitron Devices Inc common stock on August 14, 2026.

John F Chiste, a Director of Solitron Devices Inc, sold 8,000 shares of common stock on August 14, 2026 for $28.50 per share.

Howard Timothy Eriksen and 2 others reported changes in beneficial ownership of Solitron Devices Inc common stock on August 11, 2026.

Olesen Value Fund L.P. reported changes in beneficial ownership of Solitron Devices Inc common stock on July 22, 2026.

Olesen Value Fund L.P. reported changes in beneficial ownership of Solitron Devices Inc common stock on July 17, 2026.

Olesen Value Fund L.P. reported transactions involving Solitron Devices Inc. common stock on July 8th and July 10th, 2026.

Olesen Value Fund L.P. reports multiple transactions of Solitron Devices Inc. common stock.

Olesen Value Fund L.P. reports significant transactions in Solitron Devices Inc. common stock.

Howard Timothy Eriksen, a Director and CEO of Solitron Devices Inc., reported a transaction involving common stock on June 5, 2026.

Solitron Devices' President and COO, Mark Matson, acquired 5,000 shares of common stock at $21.22 per share under a 10b5-1 plan.

Solitron Devices' President and COO, Mark Matson, acquired 5,000 shares of common stock at $18.01 per share, increasing his direct beneficial ownership to 233,573 shares.

Solitron Devices' President and COO, Mark Matson, acquired 50,000 shares of common stock at $14.50 per share under a 10b5-1 plan.

Olesen Value Fund L.P. and its affiliated entities sold 879 shares of Solitron Devices Inc. common stock at $16.99 per share, reducing their total beneficial ownership to 236,508 shares.

Olesen Value Fund L.P. and related entities reported sales of Solitron Devices Inc. common stock totaling 2,100 shares across three transactions in August 2025.

Olesen Value Fund L.P., a 10% owner of Solitron Devices Inc., reported sales of common stock totaling 12,801 shares across three transactions in mid-August 2025.

Solitron Devices Director David W. Pointer was granted 2,000 shares of common stock, immediately vested under the company's 2019 Stock Incentive Plan.

Solitron Devices, Inc. Director and 10% owner Dwight P. Aubrey received a grant of 2,000 shares of common stock, increasing his beneficial ownership to 8,000 shares.

Solitron Devices Director John F. Chiste received a grant of 2,000 shares of common stock, immediately vested, under the company's 2019 Stock Incentive Plan.

A Solitron Devices director received a grant of 2,000 common shares, increasing their total beneficial ownership to 8,000 shares.

Solitron Devices' President and COO, Mark Matson, was granted 2,000 shares of common stock, immediately vested under the company's 2019 Stock Incentive Plan.

Carolyn K. Campbell, CFO of Solitron Devices Inc. (SODI), was granted 2,000 shares of common stock, immediately vested under the company's 2019 Stock Incentive Plan.

Solitron Devices CEO Howard Timothy Eriksen received a grant of 2,000 common shares, immediately vested under the company's 2019 Stock Incentive Plan.

Olesen Value Fund L.P. and related entities reported planned sales of Solitron Devices Inc. common stock totaling 4,220 shares in early August 2025 under a Rule 10b5-1 plan.

Olesen Value Fund L.P. and related entities have decreased their holdings in Solitron Devices Inc. through a series of transactions between November 25, 2024, and December 23, 2024.

Olesen Value Fund L.P. and related entities have reported multiple sales of Solitron Devices Inc. common stock between October 7, 2024 and November 19, 2024.

Olesen Value Fund L.P., along with related entities and Christian Olesen, sold shares of Solitron Devices Inc. (SODI) between September 3, 2024, and October 1, 2024, reducing their holdings.

Olesen Value Fund L.P. reports the sale of Solitron Devices Inc. shares across multiple transactions, slightly decreasing its holdings.

Olesen Value Fund L.P. and related entities reported the sale of common stock in Solitron Devices Inc. (SODI) between August 14 and August 26, 2024, resulting in a slightly reduced beneficial ownership.

Olesen Value Fund L.P., along with related entities and Christian Olesen, sold shares of Solitron Devices Inc. (SODI) between August 7 and August 12, 2024.

Olesen Value Fund L.P. and related entities have been gradually decreasing their holdings in Solitron Devices Inc. through a series of transactions between July 25, 2024, and August 6, 2024.